Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

ChemoCentryx Announces Presentation of Data from Ongoing Phase Ib Clinical Trial of CCR2 Inhibitor C

firstwordpharmaJanuary 22, 2017

Tag: Immuno-Oncology , Pancreatic cancer

PharmaSources Customer Service